104 Moreover, each of the three pathways may lead to activation of the intracellular machinery of programmed cell death (PCD), suspected of being a final common mechanism of the neuron loss in PD.104 The suspected

causal factors in PD include environmental toxins, particularly enhancers of oxidative stress,105-107 and nuclear genetic defects. Evidence of mitochondrial dysfunction in PD ensured that defective mitochondrial genes linked to PD would be sought assiduously in PD Inhibitors,research,lifescience,medical patients, yet to date there is still no compelling evidence for such a link.108,109 On the other hand, studies of families in which the inheritance of PD follows mendelian patterns have already identified five genes in which mutations arc associated with typical PD phenotypes (Table II) 110,111. Genetic factors Three of the PD-related genes – PARK1, PARK2, andPARK5 – code for proteins found in LBs.110,112 Two of these – parkin (the product of PARK2) and UCH-L1 (the product, of PARK5) – are enzymatic Inhibitors,research,lifescience,medical components of the UPS for intracellular protein clearance.99 The third is α-synuclein, the product, of PARK1 and a presynaptic protein that, in the fibrillar form,

Inhibitors,research,lifescience,medical constitutes roughly 40% of a typical LB.113 A fourth gene, PARK7, codes for DJ-1, a protein linked to oxidative stress defenses and possible chaperone functions that could help to limit, misfolding of other proteins and thereby reduce Tyrphostin AG-1478 datasheet proteolytic stress.114 The fifth PD gene, NR4A2 (also known by its product’s name, NURR1),115-117 encodes a protein that regulates transcription of the TH gene and whose postmitotic expression is critical to the specification and development of midbrain DA neurons.118-121 Defects in this gene could lead to striatal DA depletion and

the characteristic Inhibitors,research,lifescience,medical motor impairments of PD, but of course such mutations by themselves would not account for the neurodegenerative process in PD, which invariably extends well beyond the midbrain Inhibitors,research,lifescience,medical and affects numerous types of nondopaminergic cell groups (Table I). Table II. Genes implicated in familial Parkinson’s disease. AD, autosomal dominant; AR, autosomal recessive; LB, Lewy body; DAT, dopamine transporter; TH, tyrosine hydroxylase. The burgeoning linkage data related to these and other why loci have reignited interest in the possibility of identifying potential susceptibility genes122-124 that might, interact with environmental factors in polygenic fashion to produce the range phenotypes observed in nonfamilial PD. Recent, evidence suggests that some PARK5 mutations may increase susceptibility to development of late-onset PD,125 while others may actually decrease susceptibility126 Thus far, however, it does not appear that single gene mutations figure prominently in sporadic PD.127-130 Moreover, twin studies have repeatedly indicated that heritability factors among patients with late-onset PD are minimal to nonexistent.